On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

Merck KGaA

FunderResearch funding and supported work

Merck KGaA is a funder indexed in ScholarIQ from OpenAlex.

What is known about Merck KGaA?

ScholarIQrecord summary

German multinational science and technology company

How many works does Merck KGaA have?

ScholarIQindexed works

Merck KGaA has 7,062 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Merck KGaA?

ScholarIQopenalex

The OpenAlex for Merck KGaA is on the source record.

What is the ROR of Merck KGaA?

ScholarIQror

The ROR for Merck KGaA is on the source record.

What are the most-cited papers on Merck KGaA?

ScholarIQmost cited works
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
Eva Pros, Maria Saigí, Daniel Alameda, Gema Gómez‐Mariano, Beatriz Martínez–Delgado, Juan J. Alburquerque-Béjar, Julián Carretero, Raúl Tonda, Anna Esteve‐Codina, I. Català, Ramón Palmero, Maria Jové, Conxi Lázaro, Ana Patiño‐García, Ignacio Gil‐Bazo, Sara Verdura, Àlex Teulé, Juan Torres‐Lanzas, David Sidransky, Noemı́ Reguart, Rubén Pı́o, Óscar Juan, Ernest Nadal, Enriqueta Felip, Luis M. Montuenga, Montse Sánchez‐Céspedes
Annals of Oncology. 202056 CitationsOPEN ACCESS
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome
Laura Mezquita, Maria Jové, Ernest Nadal, Maria Kfoury, Teresa Morán, Charles Ricordel, Marion Dhooge, Camille Tlemsani, H. Léna, Àlex Teulé, Jose-Valero Álvarez, Judith Raimbourg, Sandrine Hiret, Ludovic Lacroix, Mireia Menéndez, Juana Saldaña, Joan Brunet, P. Lianes, Isabelle Coupier, Édouard Auclin, Gonzalo Recondo, Luc Friboulet, Julien Adam, Emma Green, David Planchard, Thierry Frébourg, Gabriel Capellá, Étienne Rouleau, Conxi Lázaro, Olivier Caron, Benjamin Besse
Journal of Thoracic Oncology. 202056 Citations
ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors
Ryo Kimura, Yuta Adachi, Kentaro Hirade, Satoru Kisoda, Shogo Yanase, Norio Shibata, Makoto Ishii, Yutaka Fujiwara, Rui Yamaguchi, Yasuko Fujita, Waki Hosoda, Hiromichi Ebi
Cancers. 20240 CitationsOPEN ACCESS
470M+ articles · 14-day free trial